UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035722
Receipt number R000040693
Scientific Title A randomized, double-blind, crossover study to examine the effects of concurrent intake of alcohol and test food on cognitive function.
Date of disclosure of the study information 2019/01/30
Last modified on 2021/02/16 19:16:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized, double-blind, crossover study to examine the effects of concurrent intake of alcohol and test food on cognitive function.

Acronym

A study examining the effects of concurrent intake of alcohol and test food on cognitive function.

Scientific Title

A randomized, double-blind, crossover study to examine the effects of concurrent intake of alcohol and test food on cognitive function.

Scientific Title:Acronym

A study examining the effects of concurrent intake of alcohol and test food on cognitive function.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of concurrent intake of alcohol and test food on cognitive function in adult males.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cognitive function score

Key secondary outcomes

Breath measurement,Subjective questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Take 5 tablets of test food.

Interventions/Control_2

Take 5 tablets of placebo.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1.Adult males.
2.Those who consider having a high tolerance to alcohol.
3.Those who drink alcohol more than three times a week.

Key exclusion criteria

1.Those who have an allergy to test food ingredients.
2.Those who have a current or a past medical history of severe disease.
3.Those who are participating in another clinical trial or have participated in another clinical trial within a month.
4.In the opinion of the principal investigator, those who were determined to be unsuitable for participation in this clinical trial.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Okuyama

Organization

Kewpie Corporation

Division name

Fine Chemicals Department, Institute of Food Creation, R&D Division

Zip code

182-0002

Address

2-5-7 Sengawa cho, Chofu-shi, Tokyo

TEL

03-5384-7766

Email

yohei_okuyama@kewpie.co.jp


Public contact

Name of contact person

1st name Yui/Wei
Middle name
Last name Ou/Wang

Organization

Kewpie Corporation

Division name

Evaluation & Analysis Sciences Department, Institute of Technology Solutions, R&D Division

Zip code

182-0002

Address

2-5-7 Sengawa cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Homepage URL


Email

yui_ou@kewpie.co.jp


Sponsor or person

Institute

IMEQRD Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corporation

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Suda Clinic institutional review board

Address

2-8-14,Takadanobaba,Shinjyuku,Tokyo

Tel

03-6704-5968

Email

n-yuzawa@imeqrd.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 01 Month 11 Day

Date of IRB

2019 Year 01 Month 30 Day

Anticipated trial start date

2019 Year 01 Month 31 Day

Last follow-up date

2019 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 30 Day

Last modified on

2021 Year 02 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040693


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name